<DOC>
	<DOCNO>NCT00524615</DOCNO>
	<brief_summary>The purpose study evaluate efficacy spironolactone lower blood pressure add therapy patient resistant arterial hypertension .</brief_summary>
	<brief_title>Addition Spironolactone Patients With Resistant Arterial Hypertension</brief_title>
	<detailed_description>Arterial hypertension resistant therapy require treatment three antihypertensive drug common . At present standard therapy resistant hypertension base randomised clinical trial , neither data guide addition drug therapy . Recently observational retrospective trial report good effect spironolactone patient resistant hypertension , data validate prospective randomised clinical trial . This multicentric , randomise , double blind clinical trial , evaluate effect addition 25 mg spironolactone current medication compare placebo . The study enroll patient blood pressure 140/90 mmHg clinical examination , use least three antihypertensive drug , one diuretic . Average daytime systolic diastolic blodd pressure evaluate ABPM ( ambulatory blood pressure monitoring ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Patients 18 year Resistant arterial hypertension : ( blood pressure clinical control exceed 140/90 mmHg ( 130/80 mmHg diabetic patient patient renal disease creatinine level 133 Î¼mol per liter urinary protein excretion 300 mg 24hour period ) despite adherence treatment full dos least three antihypertensive medication , include diuretic Pregnant breastfeeding woman , woman fertile age without ruled pregnancy Severe hypertension 180/110 mmHg Renal insufficiency creatinine 180 umol/l GFR low 40 ml/min Hyperkalemia 5,4 mmol/l , hyponatremia 130 mmol/l Porphyria Hypersensitivity compound Verospiron ( Richter Gedeon , Hungary ) drug Patients take aldosterone antagonist ( spironolactone , eplerenone , kanreone )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>resistant hypertension treatment</keyword>
	<keyword>spironolactone</keyword>
	<keyword>aldosterone antagonist</keyword>
	<keyword>resistant arterial hypertension</keyword>
	<keyword>refractory arterial hypertension</keyword>
</DOC>